Nicotine-related brain disorders: the neurobiological basis of nicotine dependence
- PMID: 7712512
- PMCID: PMC11566987
- DOI: 10.1007/BF02088321
Nicotine-related brain disorders: the neurobiological basis of nicotine dependence
Abstract
1. This paper was written at a moment when the dependence liability of nicotine, the psychoactive component from tobacco, was the center of a dispute between the tobacco manufacturing companies and the scientific community (Nowak, 1994a-c). Without being comprehensive, it tries to summarize evidence compiled from several disciplines within neuroscience demonstrating that nicotine produces a true psychiatric disease, behaviorally expressed as dependence to the drug (American Psychiatric Association, 1994). Nicotine dependence has a biological substratum defined as "neuroadaptation to nicotine." 2. The first part of the article defines terms such as "abuse," "tolerance," "dependence," and "withdrawal." It discusses clinical and experimental facts at the whole-organism level, showing that animals and humans will seek and self-administer nicotine because of its rewarding properties. 3. The second part discusses the neurobiological basis of neuroadaptation to nicotine. It presents information on neuroanatomical circuits which may be involved in nicotine-related brain disorders, such as the mesocorticolimbic pathway and the basal forebrain-frontal cortex pathway. It also discusses work from several laboratories, including our own, that support the notion of a molecular basis for neuroadaptative changes induced by nicotine in the brain of a chronic smoker. 4. Although still under experimental scrutiny, the hallmark of neuroadaptation to nicotine is up-regulation of nicotinic receptors, possibly due to nicotine-induced desensitization of their function (Marks et al., 1983; Schwartz and Kellar, 1985). A correlation between these plastic changes and the behavioral data obtained from animal and human experiments is still needed to understand dependence to nicotine fully.
Similar articles
-
Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine.Mol Neurobiol. 1990 Fall-Winter;4(3-4):251-87. doi: 10.1007/BF02780343. Mol Neurobiol. 1990. PMID: 2135395 Review.
-
[Nicotine dependence].Rev Pneumol Clin. 2000 Jun;56(3):177-83. Rev Pneumol Clin. 2000. PMID: 10880944 Review. French.
-
New mechanisms and perspectives in nicotine withdrawal.Neuropharmacology. 2015 Sep;96(Pt B):223-34. doi: 10.1016/j.neuropharm.2014.11.009. Epub 2014 Nov 26. Neuropharmacology. 2015. PMID: 25433149 Free PMC article. Review.
-
Review. Neurobiology of nicotine dependence.Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3159-68. doi: 10.1098/rstb.2008.0095. Philos Trans R Soc Lond B Biol Sci. 2008. PMID: 18640919 Free PMC article. Review.
-
The neuronal pathways mediating the behavioral and addictive properties of nicotine.Handb Exp Pharmacol. 2009;(192):209-33. doi: 10.1007/978-3-540-69248-5_8. Handb Exp Pharmacol. 2009. PMID: 19184651 Review.
Cited by
-
Differences in Nicotine Encoding Dopamine Release between the Striatum and Shell Portion of the Nucleus Accumbens.Cell Transplant. 2019 Mar;28(3):248-261. doi: 10.1177/0963689718775382. Epub 2018 May 28. Cell Transplant. 2019. PMID: 29807460 Free PMC article.
-
The role of nicotinic cholinergic neurotransmission in delusional thinking.NPJ Schizophr. 2020 Jun 12;6(1):16. doi: 10.1038/s41537-020-0105-9. NPJ Schizophr. 2020. PMID: 32532978 Free PMC article. Review.
-
Differential desensitization properties of rat neuronal nicotinic acetylcholine receptor subunit combinations expressed in Xenopus laevis oocytes.Cell Mol Neurobiol. 1995 Aug;15(4):411-25. doi: 10.1007/BF02071877. Cell Mol Neurobiol. 1995. PMID: 8565045 Free PMC article.
-
Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.Cell Mol Neurobiol. 2007 Aug;27(5):609-39. doi: 10.1007/s10571-007-9149-x. Cell Mol Neurobiol. 2007. PMID: 17554626 Free PMC article. Review.
References
-
- Bommert, K., Charlton, M. P., DeBello, W. M., Chin, G. J., Betz, H., and Augustine, G. J. (1993). Inhibition of neurotransmitter release by C2-domain peptides implicates synaptotagmin in exocytosis.Nature363:163–165. - PubMed
-
- Albuquerque, E. X., Deshpande, S. S., Aracava, Y., Alkondon, M., and Daly, J. W. (1986). A possible involvement of cyclic AMP in the expression of desensitization of the nicotinic acetylcholine receptor.FEBS Lett.199:113. - PubMed
-
- Alkondon, M., and Albuquerque, E. X. (1990). Alpha-cobratoxin blocks the nicotinic acetylcholine receptor in rat hippocampal neurons.Eur. J. Pharmacol.191:505–506. - PubMed
-
- Alkondon, M., and Albuquerque, E. X. (1991). Initial characterization of the nicotinic acetylcholine receptors in rat hippocampal neurons.J. Receptor Res.11:1001–1021. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical